Alterity Therapeutics (ASX:ATH) Share Price and News - StockTrack

Market Cap (19-Sep) $125,067,280 (1,258th)	Close (30-Jun) $0.007 0 (0%)	Volume (30-Jun) 188,484	Shortsold (14-May) 14,985,846 (0.14%) (426th)
52w High $0.85	52w Low $0.350	P/E 10.33	EPS -0.07

	Subject
	ATH ATH Ann: Notice of Annual General Meeting/Proxy Form
	1 (current) 2 3
	ATH ATH Ann: Presentation of New Biomarker Data at Scientific Congress
	ATH ATH Ann: Form 20-F
	ATH ATH Ann: ATH filed Form 20-F and XBRL data with SEC
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Appendix 4G and Corporate Governance Statement 2021
	ATH ATH Ann: Appendix 4E & Annual Report 2021
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: New US Patent Expands Neurodegeneration Treatment Portfolio
	ATH ATH Ann: Appendix 4C and Quarterly Cash Flow Report
	ATH ATH Ann: New Publication Demonstrates ATH434 is Neuroprotective
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Notice under section 708A(5) of the Corporations Act
	ATH ATH Ann: Application for quotation of securities - ATH
	ATH ATH Ann: Proposed issue of securities - ATH
	ATH ATH Ann: New US patent targeting major neurodegenerative diseases
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: EU Regulatory Guidance for ATH434 Phase 2 Clinical Trial
	ATH ATH Ann: Investor Presentation
	ATH ATH Ann: Alterity to present at MST Access Investor Conference
	ATH ATH Ann: Appendix 4C and Quarterly Cash Flow Report
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Ceasing to be a substantial holder
	ATH ATH Ann: ATH434 protects brain cells and improves motor function
	ATH ATH Ann: Appendix 3G
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Alterity to present at Global Life Science Conference
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Alterity to present at 7th International Congress of MSA
	ATH ATH Ann: Half Yearly Report and Accounts
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Alterity Half Year Results and Investor Webcast Notification
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Appendix 2A and Section 708A(5) Cleansing Notice
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Proposed issue of Securities - ATH
	ATH ATH Ann: Michael J Fox grant for Parkinson's research on ATH434
	ATH ATH Ann: Appendix 4C and Quarterly Cash Flow Report
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Alterity participates in JP Morgan healthcare conference
	ATH ATH Ann: Dr David Stamler Appointed CEO
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Form F-3

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.01	8,521,381	0.00 (12.00%)
12-Sep	$0.01	1,963,777	+0.00 (4.17%)
11-Sep	$0.01	2,408,866	0.00 (7.69%)
05-Sep	$0.01	0	0.00 (0.00%)
04-Sep	$0.01	0	0.00 (0.00%)
03-Sep	$0.01	19,161,429	0.00 (7.14%)
29-Aug	$0.01	4,903,080	+0.00 (16.67%)
28-Aug	$0.01	318,486	0.00 (0.00%)
22-Aug	$0.01	26,337,350	0.00 (11.11%)
21-Aug	$0.01	871,207	0.00 (3.57%)
15-Aug	$0.01	4,101,499	+0.00 (7.69%)
14-Aug	$0.01	1,801,308	0.00 (0.00%)
07-Aug	$0.01	8,854,447	0.00 (7.14%)
31-Jul	$0.01	13,509,843	0.00 (0.00%)
30-Jul	$0.01	19,658,371	0.00 (6.67%)
3 up, 7 down, and 5 flat days

High $0.01	Low $0.01	Trades 19	Turnover $1,131	Volume 188,484
30 June 2023 at 4:10pm

High $0.01	Low $0.01	Trades 19	Turnover $1,131	Volume 188,484
30 June 2023 at 4:10pm

Alterity Therapeutics Health Care

$0.007 0.001 (16.67%)

$0.007 0.001 (16.67%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices